The largest database of trusted experimental protocols

V2 kits

Manufactured by Illumina
Sourced in United States

The V2 kits are a set of reagents and consumables designed for use with Illumina sequencing instruments. These kits provide the necessary components to perform library preparation and sequencing reactions. The core function of the V2 kits is to enable the generation of high-quality sequencing data from DNA or RNA samples.

Automatically generated - may contain errors

4 protocols using v2 kits

1

Comprehensive Mutation Analysis of Paraffin-Embedded Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
The DNA was extracted from paraffin-embedded tissue blocks by the Cobas DNA Sample Preparation Kit (Roche) according to manufacturer’s protocol. Mutation analysis was performed by multiparallel sequencing (NGS). Indexed Illumina NGS library was constructed from 100 ng tumor DNA by KAPA Library Preparation Hyper Plus Kit (Kapa Biosystems). Hybrid selection was performed with a custom SeqCap EZ Choice Library (Roche NimbleGen). The library was designed using genome build hg19 NCBI. Build 37.1/GRCh37 input genomic regions are listed as follows: AKT, BRAF (exons 11,15), BRCA1, BRCA2, EGFR (exons 18, 19, 20, 21), ESR, GNAS (exon 8), KRAS, KIT, MLH1, MSH2, MSH6, NRAS, PDGFRA (exons 8, 10, 12, 14, 18), PIK3CA, PMS2, PTEN, RET and TP53.
Paired-end cluster generation and sequencing were performed according to standard protocols from Illumina, using v2 kits. Sequencing data analysis and variant classification were performed by NextGENe software (Softgenetics) with minimum 5% variant allele frequency filtering.
+ Open protocol
+ Expand
2

Metagenomic Analysis of Bacterial Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA isolated from BS and RS samples was used for metagenomic analysis. These samples were processed and sequenced with Shotgun using Illumina ® MiSeq desktop using the 2 × 250 bp paired-end reagent V2 Kits (Illumina ®, United States) technology with a standard quantification pattern. Bioinformatic analysis and quality control were performed using the Fast QC tool (Andrews, 2017 ). Q-score was used to predict the probability of an error in base-calling. Over 75% of bases > Q30 averaged across the entire run was considered acceptable. Raw sequence reads underwent quality trimming using Trimmomatic to remove adaptor contaminants and low-quality reads (Li et al., 2010 (link)).
+ Open protocol
+ Expand
3

Nationwide SARS-CoV-2 Genome Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
With the aim of generating a random sample of viral infections across the entire country, a total of 213 samples were retrieved from six major hospitals in Israel spanning the entire geography of Israel from south to north (Table 1 and Supplementary Table 2).

Summary of samples successfully sequenced.

a
Age group
Age groupNumber of samples
0–98
10–1917
20–2942
30–3928
40–4926
50–5929
60–6931
70-7915
80–8911
90 and up3
Unknown2
b
Location and hospital
HospitalGeographic regionNumber of samples
Barzilai Medical CenterSouth coast district30
Samson Assuta Ashdod University HospitalSouth coast district23
Hadassah University Hospital - Ein KeremJerusalem district62
Poria Medical CenterNorth district26
Sheba Medical CenterTel-Aviv district51
Soroka Medical CenterSouth district20
c
SexNumber of samples
Female101
Male111

The table is divided by metadata information (a–c). Source data are provided as a Source Data file.

We obtained RNA extracted from nasopharyngeal samples. Sequencing was performed based on the V3 Artic protocol (https://artic.network/ncov-2019). Briefly, reverse transcription and multiplex PCR of 109 amplicons was performed, and adapters were ligated to allow for sequencing. All samples were run on an Illumina Miseq using 250-cycle V2 kits in the Technion Genome Center (Israel). Supplementary Table 13 contains all primer names and sequences as described in the Artic protocol.
+ Open protocol
+ Expand
4

Targeted NGS Profiling of Common Oncogenes

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from formalin-fixed, paraffin embedded tumour tissue after deparaffinization in xylene and rehydration in ethanol using the commercial DNA Sample Preparation Kit (Roche, Basel, Switzerland) according to the manufacturer's protocol. Mutation analysis was performed by Massively Parallel Sequencing (NGS). Indexed Illumina NGS library was constructed from 100 ng tumour cell line DNA using KAPA Library Preparation Hyper Plus Kit (Kapa Biosystems). Hybrid selection was performed with a custom SeqCap EZ Choice Library (Roche NimbleGen). The library was designed using the genome build hg19 NCBI Build 37.1/GRCh37 (input genomic regions: KRAS NM_004985.4 -full coding regions; NRAS NM_002524.4 -full coding regions; BRAF NM_004333.4 -exons 11 a 15; PTEN NM_000314.4 -full coding regions). Paired-end cluster generation and sequencing were performed according to standard protocols from Illumina, using v2 kits. Sequencing data analysis and variant annotation was performed using NextGENe software (Softgenetics) with minimum 5% variant allele frequency filtering.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!